{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:26:17Z","timestamp":1788452777446,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Qingdao Clinical Research Center for Rare Diseases of the Nervous System","award":["22-3-7-lczx-3-nsh"],"award-info":[{"award-number":["22-3-7-lczx-3-nsh"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82171394"],"award-info":[{"award-number":["No.82171394"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key R&D Program of Shandong Province","award":["2022ZLGX03"],"award-info":[{"award-number":["2022ZLGX03"]}]},{"name":"Taishan Scholar Special Foundation of Shandong Province","award":["No.tsqn202408341"],"award-info":[{"award-number":["No.tsqn202408341"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Multiple acyl-CoA Dehydrogenation Deficiency (MADD) is a hereditary metabolic disorder affecting the metabolism of fatty acids, amino acids, and choline, typically presenting with fat accumulation and mitochondrial abnormalities in muscle pathology. Growth differentiation factor 15 (GDF15) is a stress-responsive cytokine implicated in energy metabolism. Therefore, this study aimed to assess the level of GDF15 in patients with late-onset MADD and to evaluate its potential as a reliable biomarker for diagnosing symptoms and determining the severity of late-onset MADD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this study, consecutive patients with MADD mitochondrial diseases were recruited from the Neuromuscular Center of Qilu Hospital, Shandong University, between April 2015 and October 2021. We measured serum GDF15 levels in patients with late-onset MADD and healthy controls. Additionally, we analyzed the messenger RNA(mRNA) expression of GDF15 and integrated stress response (ISR)-related factors, including CHOP, ATF5, and TRIB3, in the muscles.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Serum GDF15 levels in patients with late-onset MADD were 18.8 times higher than those in healthy controls. GDF15 levels decreased as the disease progressed, and its elecated levels correlated with anorexia symptoms. The mRNA expression of GDF15 and ISR-related factors in the muscles was higher in patients with late-onset MADD than in controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>GDF15 levels were significantly elevated in symptomatic patients with late-onset MADD, likely due to mitochondrial dysfunction activating the ISR pathway. These findings suggest that GDF15 is a valuable biomarker for monitoring disease severity and symptomatology in patients with late-onset MADD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03651-1","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T10:43:08Z","timestamp":1743763388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Growth differentiation factor 15: a valuable biomarker for the diagnosis and prognosis of late-onset form of multiple Acyl-CoA dehydrogenation deficiency"],"prefix":"10.1186","volume":"20","author":[{"given":"Sun","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang","family":"Shuyao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyu","family":"Jingwei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Bing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Jingwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Busu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Bing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Kunqian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2191-5184","authenticated-orcid":false,"given":"Yan","family":"Chuanzhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"issue":"16","key":"3651_CR1","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1093\/hmg\/ddu146","volume":"23","author":"N Cornelius","year":"2014","unstructured":"Cornelius N, Corydon TJ, Gregersen N, Olsen RK. Cellular consequences of oxidative stress in riboflavin responsive multiple acyl-CoA dehydrogenation deficiency patient fibroblasts. Hum Mol Genet. 2014;23(16):4285\u2013301.","journal-title":"Hum Mol Genet"},{"key":"3651_CR2","unstructured":"Prasun P et al. Multiple Acyl-CoA Dehydrogenase Deficiency. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, editors. GeneReviews((R)). Seattle (WA)1993."},{"issue":"5","key":"3651_CR3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/ana.25338","volume":"84","author":"J Xu","year":"2018","unstructured":"Xu J, Li D, Lv J, Xu X, Wen B, Lin P, et al. ETFDH mutations and flavin adenine dinucleotide homeostasis disturbance are essential for developing Riboflavin-Responsive multiple Acyl-Coenzyme A dehydrogenation deficiency. Ann Neurol. 2018;84(5):659\u201373.","journal-title":"Ann Neurol"},{"issue":"4","key":"3651_CR4","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.55730\/1300-0144.5431","volume":"52","author":"J Han","year":"2022","unstructured":"Han J, Lu S, Song X, Ji G, Xie Y, Wu H. The clinical, pathological, and genetic characteristics of lipid storage myopathy in Northern China. Turk J Med Sci. 2022;52(4):1256\u201365.","journal-title":"Turk J Med Sci"},{"issue":"5","key":"3651_CR5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/10408363.2019.1615034","volume":"56","author":"S Desmedt","year":"2019","unstructured":"Desmedt S, Desmedt V, De Vos L, Delanghe JR, Speeckaert R, Speeckaert MM. Growth differentiation factor 15: A novel biomarker with high clinical potential. Crit Rev Clin Lab Sci. 2019;56(5):333\u201350.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"3","key":"3651_CR6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4093\/dmj.2020.0087","volume":"44","author":"JY Chang","year":"2020","unstructured":"Chang JY, Hong HJ, Kang SG, Kim JT, Zhang BY, Shong M. The role of growth differentiation factor 15 in energy metabolism. Diabetes Metab J. 2020;44(3):363\u201371.","journal-title":"Diabetes Metab J"},{"key":"3651_CR7","doi-asserted-by":"crossref","unstructured":"Laurens C, Parmar A, Murphy E, Carper D, Lair B, Maes P et al. Growth and differentiation factor 15 is secreted by skeletal muscle during exercise and promotes lipolysis in humans. JCI Insight. 2020;5(6).","DOI":"10.1172\/jci.insight.131870"},{"key":"3651_CR8","doi-asserted-by":"crossref","unstructured":"Johann K, Kleinert M, Klaus S. The role of GDF15 as a myomitokine. Cells. 2021;10(11).","DOI":"10.3390\/cells10112990"},{"key":"3651_CR9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pharmthera.2019.02.008","volume":"198","author":"SJ Baek","year":"2019","unstructured":"Baek SJ, Eling T. Growth differentiation factor 15 (GDF15): A survival protein with therapeutic potential in metabolic diseases. Pharmacol Ther. 2019;198:46\u201358.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"3651_CR10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cmet.2018.12.016","volume":"29","author":"S Patel","year":"2019","unstructured":"Patel S, Alvarez-Guaita A, Melvin A, Rimmington D, Dattilo A, Miedzybrodzka EL, et al. GDF15 provides an endocrine signal of nutritional stress in mice and humans. Cell Metab. 2019;29(3):707\u201318. e8.","journal-title":"Cell Metab"},{"issue":"3","key":"3651_CR11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1432-1033.2003.03946.x","volume":"271","author":"S Ghisla","year":"2004","unstructured":"Ghisla S, Thorpe C. Acyl-CoA dehydrogenases. A mechanistic overview. Eur J Biochem. 2004;271(3):494\u2013508.","journal-title":"Eur J Biochem"},{"issue":"19","key":"3651_CR12","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1093\/hmg\/ddt232","volume":"22","author":"N Cornelius","year":"2013","unstructured":"Cornelius N, Byron C, Hargreaves I, Guerra PF, Furdek AK, Land J, et al. Secondary coenzyme Q10 deficiency and oxidative stress in cultured fibroblasts from patients with riboflavin responsive multiple Acyl-CoA dehydrogenation deficiency. Hum Mol Genet. 2013;22(19):3819\u201327.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"3651_CR13","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.freeradbiomed.2007.08.011","volume":"43","author":"KS Echtay","year":"2007","unstructured":"Echtay KS. Mitochondrial uncoupling proteins\u2013what is their physiological role? Free Radic Biol Med. 2007;43(10):1351\u201371.","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"3651_CR14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.tibs.2012.02.004","volume":"37","author":"F Fischer","year":"2012","unstructured":"Fischer F, Hamann A, Osiewacz HD. Mitochondrial quality control: an integrated network of pathways. Trends Biochem Sci. 2012;37(7):284\u201392.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"3651_CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1083\/jcb.201607110","volume":"216","author":"HK Chung","year":"2017","unstructured":"Chung HK, Ryu D, Kim KS, Chang JY, Kim YK, Yi HS, et al. Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis. J Cell Biol. 2017;216(1):149\u201365.","journal-title":"J Cell Biol"},{"issue":"10","key":"3651_CR16","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1007\/s12035-016-0283-7","volume":"54","author":"X Ji","year":"2017","unstructured":"Ji X, Zhao L, Ji K, Zhao Y, Li W, Zhang R, et al. Growth differentiation factor 15 is a novel diagnostic biomarker of mitochondrial diseases. Mol Neurobiol. 2017;54(10):8110\u20136.","journal-title":"Mol Neurobiol"},{"key":"3651_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2164-15-91","volume":"15","author":"SG Kalko","year":"2014","unstructured":"Kalko SG, Paco S, Jou C, Rodriguez MA, Meznaric M, Rogac M, et al. Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies. BMC Genomics. 2014;15:91.","journal-title":"BMC Genomics"},{"issue":"5","key":"3651_CR18","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ana.24506","volume":"78","author":"S Yatsuga","year":"2015","unstructured":"Yatsuga S, Fujita Y, Ishii A, Fukumoto Y, Arahata H, Kakuma T, et al. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders. Ann Neurol. 2015;78(5):814\u201323.","journal-title":"Ann Neurol"},{"key":"3651_CR19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mito.2019.10.005","volume":"50","author":"NS Poulsen","year":"2020","unstructured":"Poulsen NS, Madsen KL, Hornsyld TM, Eisum AV, Fornander F, Buch AE, et al. Growth and differentiation factor 15 as a biomarker for mitochondrial myopathy. Mitochondrion. 2020;50:35\u201341.","journal-title":"Mitochondrion"},{"issue":"3","key":"3651_CR20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bbrc.2017.08.096","volume":"498","author":"D Li","year":"2018","unstructured":"Li D, Zhang H, Zhong Y. Hepatic GDF15 is regulated by CHOP of the unfolded protein response and alleviates NAFLD progression in obese mice. Biochem Biophys Res Commun. 2018;498(3):388\u201394.","journal-title":"Biochem Biophys Res Commun"},{"key":"3651_CR21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-physiol-022020-045449","volume":"83","author":"SN Breit","year":"2021","unstructured":"Breit SN, Brown DA, Tsai VW. The GDF15-GFRAL pathway in health and metabolic disease: friend or foe?? Annu Rev Physiol. 2021;83:127\u201351.","journal-title":"Annu Rev Physiol"},{"issue":"18","key":"3651_CR22","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/sj.onc.1206367","volume":"22","author":"AJ Bowers","year":"2003","unstructured":"Bowers AJ, Scully S, Boylan JF. SKIP3, a novel Drosophila tribbles ortholog, is overexpressed in human tumors and is regulated by hypoxia. Oncogene. 2003;22(18):2823\u201335.","journal-title":"Oncogene"},{"issue":"10","key":"3651_CR23","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm.4394","volume":"23","author":"L Yang","year":"2017","unstructured":"Yang L, Chang CC, Sun Z, Madsen D, Zhu H, Padkjaer SB, et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat Med. 2017;23(10):1158\u201366.","journal-title":"Nat Med"},{"issue":"10","key":"3651_CR24","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm.4392","volume":"23","author":"SE Mullican","year":"2017","unstructured":"Mullican SE, Lin-Schmidt X, Chin CN, Chavez JA, Furman JL, Armstrong AA, et al. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat Med. 2017;23(10):1150\u20137.","journal-title":"Nat Med"},{"issue":"10","key":"3651_CR25","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.4393","volume":"23","author":"PJ Emmerson","year":"2017","unstructured":"Emmerson PJ, Wang F, Du Y, Liu Q, Pickard RT, Gonciarz MD, et al. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med. 2017;23(10):1215\u20139.","journal-title":"Nat Med"},{"issue":"7675","key":"3651_CR26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature24042","volume":"550","author":"JY Hsu","year":"2017","unstructured":"Hsu JY, Crawley S, Chen M, Ayupova DA, Lindhout DA, Higbee J, et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature. 2017;550(7675):255\u20139.","journal-title":"Nature"},{"key":"3651_CR27","doi-asserted-by":"crossref","unstructured":"Sigvardsen CM, Richter MM, Engelbeen S, Kleinert M, Richter EA. GDF15 is still a mystery hormone. Trends Endocrinol Metab. 2024.","DOI":"10.1016\/j.tem.2024.09.002"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03651-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03651-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03651-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T10:43:44Z","timestamp":1743763424000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03651-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3651"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03651-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"26 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Qilu Hospital Institutional Ethics Committee","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Written informed consent for publication was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"159"}}